Doma Perpetual Capital Management LLC Pacira Bio Sciences, Inc. Transaction History
Doma Perpetual Capital Management LLC
- $254 Billion
- Q1 2025
A detailed history of Doma Perpetual Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Doma Perpetual Capital Management LLC holds 1,804,069 shares of PCRX stock, worth $40 Million. This represents 17.62% of its overall portfolio holdings.
Number of Shares
1,804,069
Previous 1,747,849
3.22%
Holding current value
$40 Million
Previous $32.9 Billion
36.14%
% of portfolio
17.62%
Previous 16.39%
Shares
7 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
51.1MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$178 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$120 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$53.2 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$50 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$47.7 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.02B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...